As of November 6, 2026, OptimizeRx Corp is a publicly traded company (Nasdaq: OPRX); its largest reported holder is Royce & Associates LP, with 6.98% on Schedule 13G/A of October 21, 2026, then Kennedy Capital Management LLC (6.7%) (Schedule 13G/A, October 21, 2026).
Is this your company?
About to sign with, pay or invest in OptimizeRx Corp? See the free Snapshot first.
Free to see. No signup.
Is OptimizeRx Corp a real, registered company?
- OptimizeRx Corp files with the SEC under CIK 1448431 (its SEC filings).
- Its shares are listed under the ticker OPRX on Nasdaq (SEC company record).
- Incorporated in Nevada; business address in Waltham, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under OptimizeRx Corp in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Edward Stelmakh (Form 8-K filed 2026-08-12). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Royce & Associates LP (filed 2026-10-21).
Who are OptimizeRx Corp's owners and officers?
OptimizeRx Corp: incorporated in Nevada; business address in Waltham, Massachusetts; industry Services-Business Services, NEC (Schedule 13G/A, 2026-10-21).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-21 | Royce & Associates LP | 6.98% |
| Schedule 13G, 2026-08-14 | Kennedy Capital Management LLC | 6.7% |
| Schedule 13G/A, 2026-07-29 | Blackrock, Inc. | 1.8% |
| Schedule 13G, 2026-07-22 | Royce & Associates LP | 5.81% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2025-10-31 | The Vanguard Group | 5.7% |
| Schedule 13G/A, 2025-07-16 | Royce & Associates LP | 4.27% |
Questions about who owns OptimizeRx Corp
Who owns OptimizeRx Corp?
On this page, 2 holders' latest ownership filings report 5% or more of OptimizeRx Corp: Royce & Associates LP (6.98%, Schedule 13G/A, filed 2026-10-21) and Kennedy Capital Management LLC (6.7%, Schedule 13G, filed 2026-08-14).
Who are the largest shareholders of OptimizeRx Corp?
By the share each holder's latest filing reports, the largest holders of OptimizeRx Corp on this page are Royce & Associates LP (6.98%) and Kennedy Capital Management LLC (6.7%).
When did Royce & Associates LP buy into OptimizeRx Corp?
The filings give report dates, not purchase dates. The earliest filing from Royce & Associates LP on this page is the Schedule 13G/A, filed 2025-07-16, reporting 4.27%; its latest, Schedule 13G/A filed 2026-10-21, reports 6.98%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on OptimizeRx Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on OptimizeRx Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OptimizeRx Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-12 | Edward Stelmakh | departed | 2026-12-31 | |
| Form 8-K, 2026-08-12 | Heather Favazza | Chief Accounting Officer | appointed | 2027-01-01 |
Which insiders own OptimizeRx Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 600,852 shares (3.2% of shares outstanding) (Form 4, 2025-02-20).
- , a director: 433,837 shares (2.3% of shares outstanding) (Form 4, 2026-06-10).
- , the chief executive: 262,751 shares (1.4% of shares outstanding) (Form 4, 2026-08-24).
- , the chief legal and admin officer: 148,007 shares (0.79% of shares outstanding) (Form 4, 2026-08-24).
- , the chief finance and strat officer: 121,791 shares (0.65% of shares outstanding) (Form 4, 2026-08-24).
Shares outstanding: 18,835,951 as of 2026-07-30, from the company's latest SEC cover page.
How much has OptimizeRx Corp raised?
No fundraising or offering filing from OptimizeRx Corp is on file with us.
Keep reading
More on OptimizeRx Corp and the records around it.
OptimizeRx Corp elsewhere on the record
- Leadership changes Aug 2026
Companies that share a holder
- KENNEDY CAPITAL MANAGEMENT LLC also filed stake reports on 3 other companies: Park Dental Partners, Inc. (Oct 2026), BranchOut Food Inc. (Aug 2026), AUDIOEYE INC (May 2026)
- ROYCE & ASSOCIATES LP also filed stake reports on 61 other companies: Aetherion Technoligies Inc. (Oct 2026), Andersen Group Inc (Oct 2026), NN, Inc. (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/optimizerx